Prognostic Impact of the Initial Postoperative CA19-9 Level in Patients with Extrahepatic Bile Duct Cancer

被引：0
|
作者：
Yuichiro Kato
Shinichiro Takahashi
Naoto Gotohda
Masaru Konishi
机构：
[1] National Cancer Center Hospital East,Division of Hepatobiliary Pancreatic Surgery
来源：
Journal of Gastrointestinal Surgery | 2016年 / 20卷
关键词：
Bile duct cancer; Cholangiocarcinoma; CA19-9; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1435 / 1443
页数：8
相关论文
共 50 条
  • [31] Prognostic and predictive value of CA19-9 in metastatic colorectal cancer
    Narita, Yukiya
    Taniguchi, Hiroya
    Komori, Azusa
    Nitta, Sohhei
    Yamaguchi, Kazuhisa
    Kondoh, Chihiro
    Kadowaki, Shigenori
    Takahari, Daisuke
    Ura, Takashi
    Andoh, Masashi
    Muro, Kei
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [32] The Diagnostic Value of the CA19-9 and Bilirubin Ratio in Patients with Pancreatic Cancer, Distal Bile Duct Cancer and Benign Periampullary Diseases, a Novel Approach
    Boyd, Lenka N. C.
    Ali, Mahsoem
    Kam, Laura
    Puik, Jisce R.
    Rodrigues, Stephanie M. Fraga
    Zwart, Eline S.
    Daams, Freek
    Zonderhuis, Barbara M.
    Meijer, Laura L.
    Le Large, Tessa Y. S.
    Giovannetti, Elisa
    van Laarhoven, Hanneke W. M.
    Kazemier, Geert
    CANCERS, 2022, 14 (02)
  • [33] The prognostic value of preoperative serum levels of CEA and CA19-9 in patients with gastric cancer
    Kodera, Y
    Yamamura, Y
    Torii, A
    Uesaka, K
    Hirai, T
    Yasui, K
    Morimoto, T
    Kato, T
    Kito, T
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1996, 91 (01): : 49 - 53
  • [34] The prognostic value of combined preoperative PLR and CA19-9 in patients with resectable gallbladder cancer
    Liu, Fei
    Wang, Jun-Ke
    Ma, Wen-Jie
    Hu, Hai-Jie
    Lv, Tian-Run
    Jin, Yan-Wen
    Li, Fu-Yu
    UPDATES IN SURGERY, 2024, 76 (04) : 1235 - 1245
  • [35] Evaluation of serum CEA and CA19-9 levels as prognostic factors in patients with gastric cancer
    Kochi M.
    Fujii M.
    Kanamori N.
    Kaiga T.
    Kawakami T.
    Aizaki K.
    Kasahara M.
    Mochizuki F.
    Kasakura Y.
    Yamagata M.
    Gastric Cancer, 2000, 3 (4) : 177 - 186
  • [36] CA19-9 Level to Serum γ-Glutamyltransferase as a Potential Prognostic Biomarker in Patients with Pancreatic Head Carcinoma
    Lyu, Shao-Cheng
    Wang, Jing
    Huang, Mengxiu
    Wang, Han-Xuan
    Zhou, Lin
    He, Qiang
    Lang, Ren
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 4887 - 4898
  • [37] Impact of residual in situ carcinoma on postoperative survival in 125 patients with extrahepatic bile duct carcinoma
    Nakanishi, Yoshitsugu
    Kondo, Satoshi
    Zen, Yoh
    Yonemori, Atsuya
    Kubota, Kanako
    Kawakami, Hiroshi
    Tanaka, Eiichi
    Hirano, Satoshi
    Itoh, Tomoo
    Nakanuma, Yasuni
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2010, 17 (02) : 166 - 173
  • [38] Serum level of TSGF,CA242 and CA19-9 in pancreatic cancer
    Jing-Ting Jiang Chang-Ping Wu Hai-Feng Deng Ming-Yang Lu Jun Wu Hong-Yu Zhang Wen-Hui Sun Mei Ji Department of Tumor Biological Treatment
    World Journal of Gastroenterology, 2004, (11) : 1675 - 1677
  • [39] CA19-9 as a Predictor of Resectability in Patients with Pancreatic Cancer
    He, Z.
    Lu, H.
    Hu, W.
    Tian, B.
    Zhang, Z.
    PANCREAS, 2011, 40 (08) : 1326 - 1326
  • [40] CA19-9 and DNA ploidy in bladder cancer patients
    Khalifa, A
    AbdelFattah, MM
    Eissa, S
    Mohamed, MK
    ElDin, SAK
    CLINICAL CHEMISTRY, 1996, 42 (06) : 688 - 688
12345